Atlanta Blood Services FDA Inspection Record

FEI 3001739811 · Inspections, Form 483s, warning letters and import refusals

Atlanta Blood Services is an FDA-inspected facility (FEI 3001739811) located in Atlanta, GA, US. RegDataLab tracks 8 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Jun 4, 2026: No Action Indicated (NAI)
Inspections on record
8 (1 VAI, 7 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
24, latest Oct 17, 2024

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jun 4, 2026No Action Indicated (NAI)No citations listed
Nov 11, 2022No Action Indicated (NAI)No citations listed
Feb 6, 2019No Action Indicated (NAI)No citations listed
Oct 15, 2015No Action Indicated (NAI)No citations listed
Feb 28, 2013No Action Indicated (NAI)No citations listed
Mar 1, 2011No Action Indicated (NAI)No citations listed
Oct 28, 2009No Action Indicated (NAI)No citations listed
Nov 3, 2008Voluntary Action Indicated (VAI)Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b))

Recalls

Showing the 10 most recent of 24 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Oct 17, 2024Class IIB-0323-2025Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced
Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced, for which either the platelet yield did not meet specifications or with a…
Apr 3, 2024Class IIIB-0337-2025Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced
Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced, which were labeled with an incorrect volume, were distributed.
Mar 21, 2024Class IIIB-0399-2024Platelets, Pathogen Reduced
Pathogen Reduced Platelets product, labeled with a volume significantly lower than the product's actual volume, was distributed.
Mar 14, 2024Class IIB-0258-2024Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced
Plateletpheresis products, not meeting product specifications, were distributed.
Jul 19, 2022Class IIB-0072-2023Platelets, Pathogen Reduced
Platelets, Pathogen Reduced, which were labeled as leukocytes reduced without valid confirmation testing, were distributed.
Jul 6, 2022Class IIB-0048-2023Platelets, Pathogen Reduced
Platelets, Pathogen Reduced, which were labeled as leukocytes reduced without valid confirmation testing, were distributed.
Sep 15, 2021Class IIB-0054-2022Platelets, Pathogen Reduced
Blood product collected from a donor who was a resident of a malaria endemic area, was distributed.
May 25, 2021Class IIB-0559-2021Platelets, Pathogen Reduced
Platelets, Pathogen Reduced, with a leak detected while in the centrifuge, were distributed.
Jul 3, 2018Class IIB-0699-2018Apheresis Platelets, Leukocytes Reduced
Apheresis products collected from a donor who traveled to a malarial endemic area, were distributed.
Apr 24, 2018Class IIB-0660-2018Apheresis Granulocytes
Blood product, for which the arm prep was performed with an expired swab-stick, was distributed.

FDA record score

16 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

18 records behind this number
RecordDatePoints x age weightAdds
Class II recall B-0323-2025, this FEI as the recalling firmOct 17, 20244 x 0.62.4
Class II recall B-0258-2024, this FEI as the recalling firmMar 14, 20244 x 0.62.4
Class II recall B-0072-2023, this FEI as the recalling firmJul 19, 20224 x 0.62.4
Class II recall B-0048-2023, this FEI as the recalling firmJul 6, 20224 x 0.62.4
Class II recall B-0054-2022, this FEI as the recalling firmSep 15, 20214 x 0.251
Class II recall B-0559-2021, this FEI as the recalling firmMay 25, 20214 x 0.251
Class II recall B-0699-2018, this FEI as the recalling firmJul 3, 20184 x 0.251
Class II recall B-0660-2018, this FEI as the recalling firmApr 24, 20184 x 0.251
Class II recall B-0298-2018, this FEI as the recalling firmDec 27, 20174 x 0.251
Class II recall B-0757-2017, this FEI as the recalling firmMay 24, 20174 x 0.251
Class II recall B-0080-15, this FEI as the recalling firmAug 11, 201410 years or older, so it adds no points0
Class II recall B-0085-15, this FEI as the recalling firmAug 6, 201410 years or older, so it adds no points0
Class II recall B-1764-12, this FEI as the recalling firmDec 8, 201110 years or older, so it adds no points0
Inspection classified VAINov 3, 200810 years or older, so it adds no points0
Class II recall B-1102-6, this FEI as the recalling firmOct 17, 200510 years or older, so it adds no points0
Class II recall B-1264-6, this FEI as the recalling firmApr 4, 200510 years or older, so it adds no points0
Class II recall B-0874-6, this FEI as the recalling firmMar 31, 200510 years or older, so it adds no points0
Class II recall B-1785-4, this FEI as the recalling firmJan 28, 200410 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Atlanta Blood Services as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Atlanta Blood Services yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Atlanta Blood Services
Location
Atlanta, GA (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.